Clinical Trial Update: Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

View source ↗

Summary

This clinical trial update assesses real-world use of antiviral therapies for hepatitis C in Europe. It also evaluates the effectiveness of regimens containing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis | Status: COMPLETED